Renalytix AI plc (RENX) ORD GBP0.01 REG S
Share news, reports & tips
5 January 2021 09:31
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI announced on Tuesday that it was partnering with DaVita on a programme aimed at slowing disease progression and improving...
18 September 2020 12:49
(Sharecast News) - Artificial intelligence kidney diagnostics technology company Renalytix AI announced the commercial launch of its 'KidneyIntelX' clinical test reporting platform within the Mount...
21 August 2020 08:08
(Sharecast News) - Artificial intelligence diagnostics company Renalytix AI revealed on Friday that it will collaborate with pharmaceutical giant AstraZeneca to help improve outcomes for patients with...
12 June 2020 12:33
(Sharecast News) - Artificial intelligence (AI) in vitro diagnostics company Renalytix AI has received a clinical laboratory permit from the New York State Department of Health (NYS DOH) to provide...
10 June 2020 09:26
(Sharecast News) - Artificial intelligence (AI)-focussed diagnostics company Renalytix AI revealed more details of results from a multi-centre clinical validation of 'KidneyIntelX' on Wednesday,...
3 January 2020 08:46
(Sharecast News) - Artificial intelligence-enabled kidney disease clinical diagnostics technology company Renalytix AI announced on Friday that the United States national price for its...
3 December 2019 09:33
(Sharecast News) - Artificial intelligence-enabled kidney disease diagnostics provider Renalytix AI announced on Tuesday that the Centers for Medicare and Medicaid Services (CMS) has released the final 2020...
30 September 2019 10:10
(Sharecast News) - Artificial intelligence-enabled kidney disease clinical diagnostics developer Renalytix AI announced on Monday that Centers for Medicare & Medicaid Services (CMS) has published its...
6 August 2019 15:04
(Sharecast News) - Kidney disease artificial intelligence diagnostics developer Renalytix AI announced the expansion of its core investigator group for its lead product 'KidneyIntelX', for earlier...
29 July 2019 09:23
(Sharecast News) - Artificial intelligence-enabled diagnostics developer Renalytix AI named industry vet Thomas McLain as president and chief commercial officer of the group on Monday, effective immediately.
1 July 2019 14:56
(Sharecast News) - Artificial intelligence-based kidney disease clinical diagnostics developer Renalytix AI announced on Monday that the American Medical Association (AMA) has granted a 'CPT Proprietary...
16 June 2019 15:00
(Sharecast News) - In her 'Inside the City' column for the Sunday Times, Emma Dunkley opened by lamenting the state of the challenger bank market, writing that instead of "shaking up" the...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.